1. GCP ICH Dr. Ghiath Alahmad 2. Goals and Objectives • To understand: ▫ The affect of Good Clinical Practices on institutions conducting Clinical Research • To discuss:…

1. Cryopreserved human PBMC libraries with defined HLA-type and antigen / peptide-reactivity for accelerating and standardizing human immunological research. (c) 2009 Cellular…

1. SupportingIrish patientsand theIrish economyDevelopment of a New MedicineProvided by the IPHA Communications DepartmentMay 2010 2. Research ActivitiesThese include:Combinatorial…

1. NEW DRUG DEVELOPMENT PROCESS (NDDP) Presented by: Avinash Kumar Ch. M.Pharmacy, Dept. of Pharmacology. 2. What is a Drug..? According to the Food, Drug, and Cosmetic Act…

1. David Barounis R-2Advocate Christ Medical Center 2. Some Questions to theAudience1. How much does FFP cost and how much do you need to give in reversal of coumadin associated…

1. Clinical Trials :Overview and Opportunities Dr. KumudSarin Program DirectorBioinformatics Institute of India, Noida 2. Clinical trials are studies performed with human…

Slide 13T MR SPECTROSCOPY IN DRUG- RESISTANT TEMPORAL LOBE EPILEPSY WITH HIPPOCAMPAL ABNORMALITIES S. Battaglia 1, A.F. Marliani 1, F.Toni 1, L.Albini Riccioli 1, V. Clementi…

Slide 1ESOPHAGEAL FUNCTION TESTING IN 2011 Donald O. Castell M.D. Professor of Medicine Director, Esophageal Disorders Program Medical University of South Carolina Slide…

Slide 1 Slide 2 Diltiazem Drug Interactions: A Quality Assessment of GeneMedRx Shannon C. OHara, Pharm.D. Candidate (2007) University of Washington School of Pharmacy Genelex…

Slide 1Phosphodiesterase V Inhibitors By Lydia Zou [email protected] Doctor of Pharmacy Candidate Class of 2008 Slide 2 Goals: Historical treatments for Erectile Dysfunction…